Corporate Board Profile
Tech Score: 20/100
1 mention(s) identify CHRISTOPHER C. REEG as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| Fuse Medical, Inc. | 2023-05-10 | Mr. Reeg led the design, development, and successful commercialization of a spinal implant that received the approval of the FDA in 2013. | Mr. Reeg led the design, development, and successful commercialization of a spinal implant that received FDA approval, indicating a strong technical background in product development and engineering. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-13 | Mr. Reeg has served as our Chief Executive Officer and a member of our Board since December 19, 2016. Effective January 18, 2018, our Board appointed Mr. Reeg to the additional role of Secretary. ... 2018 Summary Compensation Table for Named Executive Officers ... Christopher C. Reeg ... $300,000 salary ... $100,000 bonus ... total $453,050. |
| 2020-04-27 | Mr. Reeg has served as our Chief Executive Officer and a member of our Board since December 19, 2016. Effective January 18, 2018, our Board appointed Mr. Reeg to the additional role of Secretary. ... Our entire Board serves as the audit committee of our Company. ... 2019 Summary Compensation Table for Named Executive Officers shows total compensation for Mr. Reeg as $302,085. |
| 2021-04-27 | Mr. Reeg has served as our Chief Executive Officer and a member of our Board since December 19, 2016. Effective January 18, 2018, our Board appointed Mr. Reeg to the additional role of Secretary. Mr. Reeg has also served as the Chief Executive Officer of CPM since 2017 and Maxim since 2018. Mr. Reeg founded Maxim in 2011 and served as its President until we acquired Maxim in August 2018. Mr. Reeg led the design, development, and successful commercialization of a spinal implant that received the approval of the FDA in 2013 and is currently manufactured and distributed by Fuse. Prior to forming Maxim, Mr. Reeg founded LMI Ortho, a distributor of spine and Orthopedic Implants purchased from domestic and international manufacturers and suppliers. While at LMI Ortho, Mr. Reeg acquired importation rights for a total joint orthopedic portfolio. Working with surgeons in the United States, Mr. Reeg expanded implant product lines and developed effective growth strategies based on design and market intelligence. Before entering the orthopedic industry with LMI Ortho in 1996, Mr. Reeg formed Spectramed, Inc., a multi-state home respiratory company where he served as its President until the sale of Spectramed, Inc., to a national healthcare company in 2001. Having founded two medical implant manufacturing and distributing companies and served as an executive officer in those companies, Mr. Reeg brings significant experience and knowledge regarding how to successfully navigate the medical device industry. |
| 2022-05-10 | Mr. Reeg has served as our Chief Executive Officer and a member of our Board since December 19, 2016. Effective January 18, 2018, our Board appointed Mr. Reeg to the additional role of Secretary. For the year ended December 31, 2021, our Board, as compensation for service as a director, offered each director, at such director's election, either (i) a $50,000 cash payment, or (ii) a stock award of $50,000 in the form of RSAs. Messrs. Brooks and Reeg elected a stock award. |
| 2023-05-10 | Mr. Reeg led the design, development, and successful commercialization of a spinal implant that received the approval of the FDA in 2013. |
Data sourced from SEC filings. Last updated: 2025-08-30